HIV protease (HIV PR) is a primary target for anti-HIV drug design. We have previously identified and characterized substituted metallacarboranes as a new class of HIV protease inhibitors. In a structure-guided drug design effort, we connected the two cobalt bis(dicarbollide) clusters with a linker to substituted ammonium group and obtained a set of compounds based on a lead formula [H(2)N-(8-(C(2)H(4)O)(2)-1,2-C(2)B(9)H(10))(1',2'-C(2)B(9)H(11))-3,3'-Co)(2)]Na. We explored inhibition properties of these compounds with various substitutions, determined the HIV PR:inhibitor crystal structure, and computationally explored the conformational space of the linker. Our results prove the capacity of linker-substituted dual-cage cobalt bis(dicarbollides) as lead compounds for design of more potent inhibitors of HIV PR.

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic v v i Gilead Sciences and IOCB Research Center Flemingovo nam 2 16610 Praha 6 Czech Republic

Citace poskytuje Crossref.org

Metallacarborane Cluster Anions of the Cobalt Bisdicarbollide-Type as Chaotropic Carriers for Transmembrane and Intracellular Delivery of Cationic Peptides

Development and characterization of a chronic hepatitis B murine model with a mutation in the START codon of an HBV polymerase

Electrochemistry of Cobalta Bis(dicarbollide) Ions Substituted at Carbon Atoms with Hydrophilic Alkylhydroxy and Carboxy Groups

Carborane-based carbonic anhydrase inhibitors: insight into CAII/CAIX specificity from a high-resolution crystal structure, modeling, and quantum chemical calculations

Nitric oxide synthases activation and inhibition by metallacarborane-cluster-based isoform-specific affectors

Cross-metathesis of allylcarboranes with O-allylcyclodextrins

Current and Novel Inhibitors of HIV Protease

Zobrazit více v PubMed

PDB
3I8W